MedPath

Enhanced Gait and Balance Training

Not Applicable
Completed
Conditions
Accidental Falls
Aging
Interventions
Device: Cranial Nerve Non-Invasive Neuromodulation
Behavioral: Sham Cranial Nerve Non-Invasive Neuromodulation
Registration Number
NCT01896466
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this study is twofold:

1. Establish baseline measures of gait performance in healthy young and older adults, and older adults with a history of falls.

2. Investigate the effects of gait and balance training with and without cranial nerve noninvasive neuromodulation (CN-NINM) on postural balance and gait performance in older adults.

For the second purpose, the study will incorporate a placebo-controlled design to evaluate the effects of CN-NINM augmented exercise compared to physical exercises alone. Both groups will perform gait and postural balance training (outlined in more detail below) but will differ in the stimulation level of the PoNS device. The investigators will use the results of this study as a first step toward evaluating the benefits of CN-NINM in a falls prevention program.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Community-dwelling

  • Able to understand and give informed consent

  • Able to stand and walk independently without an assistive device

  • No contraindication to exercise

    1. Healthy young adults
  • Between ages of 18 and 39

  • Scores above 19 on Dynamic Gait Index 2. Healthy older adults without a history of falls

  • Age 65+

  • Scores above 19 on Dynamic Gait Index 3. Older adults with a history of falls

  • Age 65+

  • Self-reported history of 1-3 falls in previous year

  • Scores of 19 and below on the Dynamic Gait Index

Exclusion Criteria
  • History of musculoskeletal disorders (lower-limb joint replacement, radiographic evidence of severe osteoarthritis, broken leg bone or ligament/tendon injury in prior 6 months)
  • Use of tobacco products
  • Any oral abrasions, cuts, cold sores, piercings, tissue inflammation, or have had oral surgery within the previous 3 months
  • Have a pacemaker or are identified as at-risk for cardiovascular events
  • Have a biomechanical prosthetic
  • If female, self-report of being pregnant
  • Neurological condition
  • Prisoners
  • Individuals clearly lacking the capacity to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy Older Adults - InterventionCranial Nerve Non-Invasive NeuromodulationHealthy subjects age 65+ will participate in Cranial Nerve Non-Invasive Neuromodulation enhanced gait and balance training.
Older Fallers - ControlSham Cranial Nerve Non-Invasive NeuromodulationSubjects who are age 65+ with a history of 1-3 falls in the previous six months will participate in Sham Cranial Nerve Non-Invasive Neuromodulation gait and balance training.
Young Adults - InterventionCranial Nerve Non-Invasive NeuromodulationHealthy subjects between the ages of 18-39 will participate in Cranial Nerve Non-Invasive Neuromodulation gait and balance training.
Healthy Older Adults - ControlSham Cranial Nerve Non-Invasive NeuromodulationHealthy subjects between age 65+ will participate in Sham Cranial Nerve Non-Invasive Neuromodulation gait and balance training.
Older Fallers - InterventionCranial Nerve Non-Invasive NeuromodulationSubjects who are age 65+ with a history of 1-3 falls in the previous six months will participate in Cranial Nerve Non-Invasive Neuromodulation enhanced gait and balance training.
Young Adult - ControlSham Cranial Nerve Non-Invasive NeuromodulationHealthy subjects between the ages of 18-39 will participate in Sham Cranial Nerve Non-Invasive Neuromodulation gait and balance training.
Primary Outcome Measures
NameTimeMethod
Dynamic Gait IndexDay 1 and approximately Day 12

An 8-item inventory of functional gait tasks each scored on a 0-3 point scale. Maximum score is 24 and any score of 19 or lower indicates an increased risk of falling.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin Hospital and Clinics

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath